MLYS: Mineralys Therapeutics Inc

MLYS Nouvelles

• Zacks 16:00 Mineralys Therapeutics, Inc. (MLYS) Upgraded to Buy: Here's Why
• Zacks 13:55 Does Mineralys Therapeutics, Inc. (MLYS) Have the Potential to Rally 154.21% as Wall Street Analysts Expect?
• Investing 21:08 Mineralys Therapeutics CEO Congleton sells $230k in shares
• Investing 21:06 Mineralys Therapeutics CFO Adam Levy sells $155k in stock
• TipRanks 10:30 3 Best Stocks to Buy Now, 7/15/2025, According to Top Analysts - TipRanks.com
• Investing 13:13 Jefferies maintains Hold rating on Mineralys stock amid AstraZeneca data
• Investing 15:25 Mineralys reports positive phase 3 results for hypertension drug
• Investing 11:31 Mineralys stock holds Buy rating at H.C. Wainwright after CKD trial
• Benzinga 13:57 Mineralys Therapeutics: Investigational Drug Shows Benefit In Hypertensive Patients With Chronic Kidney Disease, Stock Jumps - Mineralys Therapeutics (NASDAQ:MLYS)
• Investing 12:35 Mineralys Therapeutics stock jumps after positive kidney disease trial data
• Investing 11:05 Mineralys reports positive phase 2 data for lorundrostat in CKD
• Seeking Alpha 14:10 PGIM Jennison Health Sciences Fund Q1 2025 Commentary (PHLAX)
• Benzinga 12:35 This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Core Natural Resources (NYSE:CNR), Coinbase Global (NASDAQ:COIN)
• Investing 21:01 Jefferies initiates Mineralys Therapeutics stock with hold rating
• Seeking Alpha 03:36 Akebia Therapeutics (AKBA): Stock At Fair Value Amid Robust Drug Adoption Into 2026
• Seeking Alpha 15:51 Mineralys Therapeutics: Merits A Small 'Speculative' Holding (NASDAQ:MLYS)
• Investing 10:13 Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension
• Investing 12:05 Mineralys to present lorundrostat trial data at ESH 2025
• Investing 00:04 Mineralys at BofA Securities 2025: Lorundrostat’s Hypertension Promise
• TipRanks 09:35 3 Best Stocks to Buy Now, 4/1/2025, According to Top Analysts - TipRanks.com
• TipRanks 09:53 3 Best Stocks to Buy Now, 3/31/2025, According to Top Analysts - TipRanks.com
• Investing 18:40 Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology’s Annual
• Benzinga 12:36 Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Lazard (NYSE:LAZ), Amylyx Pharmaceuticals (NASDAQ:AMLX)
• Seeking Alpha 22:25 Mineralys: Prospects Just Got Better With Successful Pivotal Data Readouts (NASDAQ:MLYS)